tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Mondelez International: Strategic Reinvestments and Market Adjustments Support Buy Rating Amidst Growth Challenges

Mondelez International: Strategic Reinvestments and Market Adjustments Support Buy Rating Amidst Growth Challenges

In a report released today, Robert Moskow from TD Cowen maintained a Buy rating on Mondelez International, with a price target of $68.00.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Robert Moskow has given his Buy rating due to a combination of factors that suggest potential for future growth despite recent challenges. Mondelez International’s third-quarter organic sales growth of 3.4% fell short of expectations, and management has revised guidance downward due to increased elasticity in Europe and waning consumer confidence in the U.S. However, the company anticipates a return to high single-digit EPS growth by 2026, driven by strategic reinvestments in media, emerging market distribution, and incentives.
Despite a complex outlook, Moskow’s analysis indicates that Mondelez is taking corrective measures in Europe, where sales grew by 5% but faced significant profit declines. Management is addressing pricing strategies and promotional effectiveness to counteract these issues. In North America, although sales slightly declined, Mondelez gained market share, and management expects improvements as consumer confidence stabilizes. These strategic adjustments and growth prospects underpin Moskow’s Buy rating for the stock.

According to TipRanks, Moskow is a 3-star analyst with an average return of 3.2% and a 46.44% success rate. Moskow covers the Consumer Defensive sector, focusing on stocks such as Clorox, PepsiCo, and McCormick & Company.

In another report released yesterday, Mizuho Securities also maintained a Buy rating on the stock with a $73.00 price target.

Disclaimer & DisclosureReport an Issue

1